Opioid Withdrawal Symptoms in Critically Ill Patients

Mahidol University

Status: Completed

Conditions: Substance Withdrawal Syndrome; Critical Illness

Treatments: Drug: Opioids

Study type: Observational

Funder types: Other

Identifiers

NCT03374722

10-60-68

Details and patient eligibility

About

Most critically ill patients encounter pain and distress from acute illness, medical procedures and devices as well as routine care in the intensive care units (ICU). Opioids are principal analgesics that alleviate moderate to severe pain and facilitate patients to co-operate the course of treatment. However, prolong administration of opioids especially in mechanically ventilated patients can cause withdrawal symptoms if analgesics are rapidly weaning or acutely disruption. The opioid withdrawal symptoms (OWS) are well reported in critically ill children that cause discomfort and prolong weaning from mechanical ventilation. Weaning opioids and treatment of withdrawal symptoms are needed in order to decrease ventilator days, ICU and hospital length of stay. Conversely, there is lack of knowledge about incidence, clinical presentation, time course and appropriated assessment tool for withdrawal detection. Therefore, we conduct the study to explore an incidence of OWS, to identify factors associated OWS, to establish the assessment tool for OWS, and to report efficacy of the pharmacological treatment for OWS, in adult critically ill patients.

Full description

The primary objective of the study is to explore incidence of OWS in adult critically ill patients. The secondary objectives are 1) to identify factor associated OWS, 2) establish the assessment tool for OWS for adults and 3) to report efficacy of the pharmacological treatment in OWS in adults patients.

Enrollment: 55 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years
• On mechanical ventilator at least 24 hours
• Received continuous infusion of opioid at least 24 hours
• Patient or legal surrogate who is willing and able to provide written informed consent and comply with all protocol requirements

Exclusion criteria

• Severely disturbed behavior pattern on account of underlying neurological disease (status epilepticus, encephalopathy, head trauma, brain injury, spinal cord injury)
• Preexisting psychiatric diagnosis
• Substance abuse prior to ICU admission
• Chronic alcohol drinking
• Pregnancy
• End-of-life care
• Death during ICU admission or during opioid IV infusion

Trial design

55 participants in 1 patient group

Mechanically ventilated critically ill patients

Description:

Mechanically ventilated critically ill patients who receive opioid as continuous infusion for more than 24 hours

Treatment:

Drug: Opioids